⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research
prnewswire.com
AMGN
LLY
TEVA
PFE
ABBV
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
SNGX
IPHA
BMY
NKTX
AZN
MRK
TAK
NVS
GMAB
ABBV
BIIB
CRSP
INCY
ALKS
PFE
REGN
GILD
AMGN
Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson
globenewswire.com
AMGN
FMS
DVA
ABBV
NVS
MRK
PFE
SNY
JNJ
Polycystic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Otsuka Pharmaceutical, Novartis, Pfizer, and Vertex Pharmaceuticals
globenewswire.com
NVS
PFE
VRTX
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals
globenewswire.com
BDX
MRK
PFE
Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer
globenewswire.com
MDT
BSX
ABT
PFE
Hemorrhoids Treatment Market Research Report 2026-2036: Epidemiological Analysis, Treatment and Management, Trends, Clinical Trial Landscape, Pipeline Analysis, Regulatory Landscape
globenewswire.com
PFE
JNJ
SNY
Laryngeal Cancer Market Research Report 2026-2036, Competitive Analysis of Major Players - Merck & Co., Pfizer, Novartis, and AbbVie
globenewswire.com
MRK
PFE
ABBV
MRNA Vaccine and Therapeutics Market Research Trends and Forecast Report 2026-2035: Revolutionizing Protein Synthesis, Altering the Biomedical Scene and Paving the Way for Innovative Treatment Options
globenewswire.com
MRNA
PFE
Acute Myocardial Infarction Market is Expected to Hit Growth Stride at a CAGR of 13% During the Forecast Period (2026-2036) with New Therapeutic Innovations | DelveInsight
prnewswire.com
NVO
BMY
JNJ
AMGN
REGN
SNY
PFE
AZN
LLY
NVS